克服严重酸性喘缓解障碍:使用本拉利祖马布的两年真实世界数据
David J Jackson1,2, Hassan Burhan3,4, Hitasha Rupani5
1Guy's Severe Asthma Centre, Guy's & St Thomas' NHS Trust, London, UK.
贝纳利祖马布治疗可以在两年内导致严重的酸性喘 (SEA) 持续的临床缓解. 然而,肥胖等并发症会对缓解率产生负面影响,这凸显了综合管理策略的必要性.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 贝纳利祖马布已经显示出在一年后严重的酸性喘 (SEA) 中临床缓解的潜力.
- 缓解的长期维持和并发症的影响仍未得到充分研究.
研究的目的:
- 评估本拉利祖马布在SEA患者中实现和维持临床缓解的长期疗效.
- 确定影响本拉利祖马布治疗的SEA患者缓解率的肺和肺外并发症.
主要方法:
- 现实世界英国多中心严重喘队列的回顾性分析.
- 在开始本拉利祖马布治疗后1年和2年的临床结果和缓解率的评估.
- 记录和分析肺部和肺外共同疾病及其与缓解的关联.
主要成果:
- 在整体队列 (n=276) 中,1年后的17%和2年后的32%实现了临床缓解.
- 缓解率在1年后增加到28%,在排除患有并发症的患者时,在2年后增加到49%.
- 更高的身体质量指数 (BMI) 和维持性口服皮质类固醇 (mOCS) 使用与在两个时间点实现缓解有负面关联.
结论:
- 本拉利祖马布在现实环境中促进了SEA患者的持续临床缓解.
- 伴随性疾病,包括肥胖症,显著降低了在SEA中实现临床缓解的可能性.
- 管理并发症对于优化 SEA 中本拉利祖马布治疗结果至关重要.
更多相关视频
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
08:38Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis EAE Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge
Published on: April 9, 2012
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
